Kayser W, Euler H H, Schmitz N, Gassmann W, Löffler H, Asbeck F
Blut. 1985 Dec;51(6):401-4. doi: 10.1007/BF00320726.
Acquired amegakaryocytic thrombocytopenic purpura is a rare disease. Most reported patients did not respond to any therapeutical approach. Recently we observed a striking improvement of this disorder in a female patient shortly after therapy with danazol had been initiated. This observation and its possible implication for the treatment of amegakaryocytic thrombocytopenia are reported herein.
获得性无巨核细胞性血小板减少性紫癜是一种罕见疾病。大多数报道的患者对任何治疗方法均无反应。最近，我们观察到一名女性患者在开始使用达那唑治疗后不久，这种疾病有显著改善。本文报告了这一观察结果及其对无巨核细胞性血小板减少症治疗的可能意义。
